Newsbenzinga
BioXcel Therapeutics Announced That It Has Entered Into An Asset Sale Agreement With Teva Pharmaceuticals International For Substantially All Of The Company’s Assets
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…